EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet™ CIPN Program
04 juin 2012 00h02 HE
|
Immune Pharmaceuticals Inc
Requirements Are Consistent with FDA Guidance
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
EpiCept Reports First Quarter 2012 Operating and Financial Results
09 mai 2012 00h02 HE
|
Immune Pharmaceuticals Inc
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012
03 mai 2012 21h01 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced
today that it will host a conference...
EpiCept Makes Required Swedish Regulatory Disclosure
30 avr. 2012 17h06 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--Regulatory
News:
Pursuant to the requirements of the Swedish Financial Supervisory
Authority, EpiCept Corporation (Nasdaq OMX...
EpiCept’s AmiKet™ Receives Fast Track Designation from FDA
10 avr. 2012 00h02 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and
OTCQX: EPCT) announced today that AmiKet™ (amitriptyline 4%,...
EpiCept’s Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis
04 avr. 2012 00h02 HE
|
Immune Pharmaceuticals Inc
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory
News:
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)
announced today that new preclinical research...
EpiCept to Raise $1.1 Million in Registered Direct Offering
29 mars 2012 00h02 HE
|
Immune Pharmaceuticals Inc
EpiCept to Raise $1.1 Million in Registered Direct Offering
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--EpiCept
Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event
14 mars 2012 17h04 HE
|
Immune Pharmaceuticals Inc
EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event
BIO-Europe Spring 2012
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--
Regulatory News:
EpiCept Corporation...
EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results
29 févr. 2012 05h58 HE
|
Immune Pharmaceuticals Inc
EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial
Results
CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY
TARRYTOWN, N.Y.--(BUSINESS...
EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012
23 févr. 2012 17h02 HE
|
Immune Pharmaceuticals Inc
EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and
Financial Results on February 29, 2012
TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--...